BON USAGE CONSEIL

What BON USAGE CONSEIL does

Bon Usage Conseil is a French niche consultancy founded in 2006 and headquartered in Boulogne-Billancourt, providing quality assurance, regulatory compliance, training, and evaluation services to pharmaceutical, medical device, cosmetic, and food supplement companies. The firm operates as a SAS with €20,000 of share capital and a small team of 1-10 employees, serving more than 100 clients cumulatively across the four regulated verticals, including named enterprise accounts such as Sanofi, GSK, AstraZeneca, Gilead, and Pfizer. Its offering is structured around six service lines: on-demand consulting (Conseil à la demande), audit, consultant placement (Régie), coaching and mentoring, e-learning (E-Formation), and bespoke evaluation studies (Études).

The company's technology stack centers on three proprietary assets: the Échelle PARENT-BONIS measurement scale co-developed with B3TSI in January 2007 to evaluate medical representative visits against six physician priority expectations, backed by benchmark data from over 300 evaluations; the Evidence.p2T online platform for training evidence storage, automated reporting, and auditor response; and a SCORM-compliant e-learning catalog covering the seven mandatory themes of the French Charte de l'information promotionnelle plus specialized modules on Bonnes Pratiques de Fabrication and MSL field activities. The firm has held QUALIOPI certification since December 2020, which enables OPCO funding eligibility for client training engagements and acts as a regulatory gatekeeper in the French training market.

Bon Usage Conseil runs a quote-based, project-by-project professional services model with multi-year contract billing, supplemented by Régie staffing placements and Qualiopi-funded e-learning revenue. Distribution is exclusively direct to enterprise clients in France, with lead generation driven by its website, downloadable e-learning catalog, contact form, and industry referrals rather than paid advertising or partner channels. The firm is privately held with no parent company, no institutional investors, and no disclosed funding history.

Name

BON USAGE CONSEIL

Legal name

Bon Usage Conseil

Website

https://bonusage.fr

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

1–10 employees

Short description

Bon Usage Conseil is a French niche consultancy providing quality, regulatory, training, coaching, audit, and evaluation services to pharmaceutical, medical device, cosmetic, and food supplement companies in France, supported by proprietary tools including the Échelle PARENT-BONIS scale and the Evidence.p2T training platform.

Ownership category

akta.pro rank

Product category

Pharmaceutical Regulatory Consulting

NAICS

Management Consulting Services (54161), Management, Scientific, and Technical Consulting Services (5416)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Quality Assurance, GxP Compliance & Auditing FSP (HLAGAOAE)

akta.pro secondary industry

Regulatory Affairs & Submissions FSP (HLAGAOAD)

Keywords

• Pharmaceutical consulting services
• Regulatory compliance consulting
• Quality management systems
• E-learning training modules
• Medical device auditing

Headquarters

HQ city

Boulogne-billancourt

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Professional Services – On-Demand Consulting: Time-limited consulting engagements addressing specific quality and regulatory challenges, delivered with concrete and applicable recommendations. Revenue recognized on a project/fee basis.
2. Staffing / Contractor Placement (Régie): Placement of specialist consultants into client teams on a temporary basis, either full-time or part-time. Billed based on the duration and profile of the engagement, providing a flexible resourcing model.
3. E-Formation and Training Delivery: E-learning and in-person training services including course creation, LMS hosting, virtual classroom facilitation, and evaluation tools. Revenue recognized through training fees, with the Qualiopi certification enabling potential funding from French training finance bodies (OPCO).
4. Audit Services: Internal or shared audit engagements evaluating process compliance, identifying gaps, and prioritizing improvement actions. Billed as professional service engagements.
5. Studies and Evaluation Projects: Bespoke evaluation studies using proprietary tools (e.g., Échelle PARENT-BONIS) and methodologies for measuring promotional information quality, practice surveys, and satisfaction measurement.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Bon Usage Conseil is a France-based B2B consulting firm that delivers six core service lines — on-demand consulting (Conseil à la demande), audit, contractor placement (Régie), coaching and mentoring, e-learning/training (E-Formation), and bespoke evaluation studies (Études) — to pharmaceutical, medical device, cosmetic, and food supplement companies. Services span quality management system build-out, regulatory compliance, promotional information certification, CAPA/process improvement, and competency development, supported by the proprietary Evidence.p2T training-evidence platform and the Échelle PARENT-BONIS medical-visit quality scale.

Product overview

Bon Usage Conseil is a consulting company offering a portfolio of interconnected services for the pharmaceutical, cosmetic, medical device, and food supplement industries. The core offering consists of six main service lines: Conseil à la demande (on-demand consulting), Audit, Régie (consultant placement), Coaching & Mentoring, E-Formation (e-learning), and Études (evaluation studies). Supporting these services are proprietary tools including Evidence.p2T for training traceability and the Échelle PARENT-BONIS for promotional quality measurement. The e-learning catalog features 7 regulatory-themed modules (Charte et certification, Pharmacovigilance, Déontologie, Publicité, Organisation du système de soins, Médicament, and Modalités de prise en charge) plus specialized modules for MSL and BPF. The company operates on a modular service model where clients can engage individual services or combine them for comprehensive support throughout product lifecycle.

Differentiator

Problem solved

Functional benefit

Products and services

• Conseil à la demande

Quantifiable outcome

• 30% reduction in non-conformities in quality control processes
• +3 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• B3TSIcoreStrategic or Co-development Partner · 8 January 2007B3TSI collaborated with Bon Usage Conseil to create the Échelle PARENT-BONIS, a measurement scale for evaluating the quality of medical visits targeting physicians. The scale was created on 8 January 2007 and has since been used in over 300 evaluations, generating benchmark data.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• IQVIA: Global life-sciences services and technology firm spanning CRO, consulting, real-world evidence, and commercial services. Overlaps with Bon Usage Conseil's pharma advisory work as part of a much broader portfolio.
• Parexel: Global CRO with biopharmaceutical services including regulatory, quality, and clinical consulting. Operates broadly across pharma services where Bon Usage Conseil plays in a niche QA/regulatory role.
• Bureau Veritas: Global testing, inspection, and certification firm with a healthcare and life-sciences practice offering certification audits and training. Comparable audit-and-training offering for pharma enterprise clients.
• Charles River Laboratories: Global life-sciences services firm spanning research models, drug discovery, safety assessment, and manufacturing support. Serves pharma enterprise clients with quality and compliance-adjacent services.
• SGS: Global testing, inspection, and certification company with life-sciences practice offering audit, training, and quality compliance services. Comparable in the audit/training dimension but operates at vastly broader scale.
• ICON plc: Global CRO providing clinical research, consulting, and commercialization services to pharma and biotech. Comparable as a large incumbent serving pharma clients with overlapping consulting and compliance capabilities.

Direct peers

• Aixial Group: European CRO and pharma services firm offering clinical, regulatory, and quality consulting with strong presence in France. Comparable as a pharma-services provider combining consulting, staffing, and regulatory expertise.
• Ypso-Facto: French consulting firm specialized in pharmaceutical quality, regulatory affairs, and industrial performance. Direct overlap with Bon Usage Conseil's quality/GxP and regulatory consulting offering for pharma clients.
• Alcimed: French-headquartered healthcare and life-sciences strategy and innovation consulting firm serving pharma, biotech, and medical-device clients. Comparable as a boutique European consultancy focused on health-industry advisory work for enterprise clients.

Emerging players

• PharmaLex (Cencora): Specialized pharmaceutical regulatory affairs and consulting firm (now part of Cencora) offering regulatory strategy, submissions, and compliance services. Comparable as a pharma-focused regulatory/quality services specialist competing in the same niche.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/bonusageconseil

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BON USAGE CONSEIL